Viatris Inc. reported total revenues of $3,760 million for the third quarter of 2025, a slight increase from $3,751 million in the same period last year. Adjusted EBITDA was $1,155 million, down 10% from the previous year, while adjusted earnings per share declined 11% to $0.67. Free cash flow reached $658 million, a 12% decrease year-over-year. The company noted strong growth in China and across e-commerce, retail, and private hospital channels, as well as benefits from the timing of customer purchasing patterns. Viatris also indicated substantial completion of initial remediation activities at its Indore site and recent discussions with the US FDA regarding remediation progress.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viatris Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.